image
Healthcare - Drug Manufacturers - Specialty & Generic - OTC - US
$ 0.0002
0 %
$ 351
Market Cap
None
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one CLVR stock under the worst case scenario is HIDDEN Compared to the current market price of 0.0002 USD, Clever Leaves Holdings Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one CLVR stock under the base case scenario is HIDDEN Compared to the current market price of 0.0002 USD, Clever Leaves Holdings Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one CLVR stock under the best case scenario is HIDDEN Compared to the current market price of 0.0002 USD, Clever Leaves Holdings Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLVR

image
$1.0$1.0$0.9$0.9$0.8$0.8$0.7$0.7$0.6$0.6$0.5$0.5$0.4$0.4$0.3$0.3$0.2$0.2$0.1$0.1$0.0$0.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
17.4 M REVENUE
-2.15%
-15.6 M OPERATING INCOME
46.52%
-19.8 M NET INCOME
70.08%
-11.5 M OPERATING CASH FLOW
60.41%
4.69 M INVESTING CASH FLOW
293.79%
656 K FINANCING CASH FLOW
-80.05%
4.64 M REVENUE
21.41%
-4.91 M OPERATING INCOME
-45.45%
-5.08 M NET INCOME
1.03%
-1.54 M OPERATING CASH FLOW
29.90%
2.06 M INVESTING CASH FLOW
-24.33%
-162 K FINANCING CASH FLOW
-21.32%
Balance Sheet Clever Leaves Holdings Inc.
image
Current Assets 13.9 M
Cash & Short-Term Investments 6.83 M
Receivables 2.08 M
Other Current Assets 5.03 M
Non-Current Assets 17.3 M
Long-Term Investments 0
PP&E 13.2 M
Other Non-Current Assets 4.15 M
21.86 %6.65 %16.10 %42.09 %13.29 %Total Assets$31.2m
Current Liabilities 5.81 M
Accounts Payable 2.06 M
Short-Term Debt 884 K
Other Current Liabilities 2.86 M
Non-Current Liabilities 1.22 M
Long-Term Debt 1.2 M
Other Non-Current Liabilities 12 K
29.36 %12.58 %40.76 %17.12 %Total Liabilities$7.0m
EFFICIENCY
Earnings Waterfall Clever Leaves Holdings Inc.
image
Revenue 17.4 M
Cost Of Revenue 10.9 M
Gross Profit 6.56 M
Operating Expenses 21.2 M
Operating Income -15.6 M
Other Expenses 4.2 M
Net Income -19.8 M
20m20m15m15m10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)17m(11m)7m(21m)(16m)(4m)(20m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
37.64% GROSS MARGIN
37.64%
-89.53% OPERATING MARGIN
-89.53%
-102.77% NET MARGIN
-102.77%
-73.91% ROE
-73.91%
-57.29% ROA
-57.29%
-59.46% ROIC
-59.46%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Clever Leaves Holdings Inc.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)201920192020202020212021202220222023202320242024
Net Income -19.8 M
Depreciation & Amortization 2.85 M
Capital Expenditures -31 K
Stock-Based Compensation 818 K
Change in Working Capital 135 K
Others 3.56 M
Free Cash Flow -11.5 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Clever Leaves Holdings Inc.
image
CLVR has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Clever Leaves Holdings Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Clever Leaves Announces Voluntary Delisting and SEC Deregistration TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasdaq Stock Market LLC (“Nasdaq”) and deregister its Securities in order to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). globenewswire.com - 1 year ago
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, is reporting financial and operating results for the fourth quarter and full year ended December 31, 2023. All financial information is provided in US dollars unless otherwise indicated. globenewswire.com - 1 year ago
High Growth: Top Pot Stocks Making Moves into March 2024 As the cannabis industry continues to flourish in the United States, investors are keenly watching the market for top-performing marijuana stocks. With the industry projected to reach a staggering $30 billion by 2025, the allure of double-digit gains before March is strong. Recent updates on federal legalization efforts have further invigorated the market. These developments promise to expand the industry's legal framework, potentially unlocking vast untapped markets. Investors are advised to employ technical analysis and proper risk management strategies. These tools are crucial for navigating the volatile cannabis sector. They help identify promising entry and exit points, maximizing returns while minimizing risks. marijuanastocks.com - 1 year ago
Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for cultivation across Colombia and Latin America. The two companies have already begun rigorous selection, phenotyping, and agronomic trials of several Paradise varieties at Clever Leaves' facility in order to register market-leading cultivars for production and commercialization. globenewswire.com - 1 year ago
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. globenewswire.com - 1 year ago
Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of Investors. businesswire.com - 1 year ago
Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder SAN DIEGO--(BUSINESS WIRE)---- $CLVR #CleverLeavesHoldingsInc--Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of Shareholder. businesswire.com - 1 year ago
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which merged with Clever Leaves Holdings Inc. (“Clever Leaves”) (NASDAQ: CLVR) on December 17, 2020. Investors who purchased Schultze are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/clvr. Inv. businesswire.com - 1 year ago
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses NEW YORK--(BUSINESS WIRE)---- $CLVR #classaction--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schultze Special Purpose Acquisition Corp. (NASDAQ: SAMA, SAMAW, and SAMAU) (“Schultze”), which merged with Clever Leaves Holdings Inc. (“Clever Leaves”) (NASDAQ: CLVR) on December 17, 2020. Investors who purchased Schultze are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/clvr. In. businesswire.com - 1 year ago
Clever Leaves Holdings, Inc. (CLVR) Q3 2023 Earnings Call Transcript Clever Leaves Holdings, Inc. (NASDAQ:CLVR ) Q3 2023 Earnings Conference Call November 9, 2023 5:00 PM ET Company Participants Jackie Keshner - Director of Investor Relations Andres Fajardo - Chief Executive Officer Hank Hague - Chief Financial Officer Conference Call Participants Bobby Burleson - Canaccord Genuity Operator Good day, and welcome Clever Leaves Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. seekingalpha.com - 1 year ago
Clever Leaves Reports Third Quarter 2023 Results - Q3 Revenue Increased 33% Year-Over-Year, Propelled by 135% Year-Over-Year Growth in Cannabinoid Revenue, Along with 6% Year-Over-Year Growth in Non-Cannabinoid Revenue - globenewswire.com - 1 year ago
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ET TOCANCIPÁ, Colombia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, will hold a conference call on Thursday, November 9, 2023 at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2023. The Company will provide its financial results in a press release prior to the conference call. globenewswire.com - 1 year ago
8. Profile Summary

Clever Leaves Holdings Inc. CLVR

image
COUNTRY US
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 351
Dividend Yield 0.00%
Description Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Contact 6501 Congress Avenue, Boca Raton, FL, 33487 https://www.cleverleaves.com
IPO Date Dec. 18, 2020
Employees 296
Officers Ms. Jackie Keshner Investor Relations Executive Mr. Julian Wilches Chief Regulatory Officer Mr. Gustavo Escobar Chief Operating Officer Mr. Andres Fajardo Co-Founder, Chief Executive Officer & Director Mr. Camilo Bohorquez Head of Colombia Ms. Marta Pinto Leite General Counsel & Corporate Secretary Ms. Caroline Kliess Managing Director of Germany Mr. Henry R. Hague III Chief Financial Officer Mr. Andrew Miller Head of Business Development